发明名称 |
Chronic myeloid leukemia (cml) therapy |
摘要 |
<p>Methods for treating treatment-naive as well as treatment-experienced patients havingCML to achieve at least a partial cytogenetic response involving administering a therapeutically effective amount of pegylated interferon-alfa, e.g. , pegylated interferon alfa-2b as monotherapy or in association with a therapeutically effective amount of Ara-C are disclosed.</p> |
申请公布号 |
EP1043024(A2) |
申请公布日期 |
2000.10.11 |
申请号 |
EP20000107099 |
申请日期 |
2000.04.06 |
申请人 |
SCHERING CORPORATION |
发明人 |
RYBAK, MARY ELLEN;ROSE, ESTHER HELEN |
分类号 |
A61K38/21;A61P35/02;A61P43/00;(IPC1-7):A61K38/21;A61P35/00;A61K47/48 |
主分类号 |
A61K38/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|